Fulgent Genetics, Inc.

NASDAQ:FLGT

19.7 (USD) • At close May 9, 2025
Bedrijfsnaam Fulgent Genetics, Inc.
Symbool FLGT
Munteenheid USD
Prijs 19.7
Beurswaarde 599,738,920
Dividendpercentage 0%
52-weken bereik 14.57 - 25.11
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Ming Hsieh
Website https://www.fulgentgenetics.com

An error occurred while fetching data.

Over Fulgent Genetics, Inc.

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for

Vergelijkbare Aandelen

Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc.

AUPH

8 USD

BioCryst Pharmaceuticals, Inc. logo

BioCryst Pharmaceuticals, Inc.

BCRX

9.97 USD

SpringWorks Therapeutics, Inc. logo

SpringWorks Therapeutics, Inc.

SWTX

46.26 USD

Apollo Medical Holdings, Inc. logo

Apollo Medical Holdings, Inc.

AMEH

40.82 USD

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

0.709 USD

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

3.89 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)